The use of medication to manage behaviour problems in adults with an intellectual disability: A national guideline

Advances in Mental Health and Intellectual Disabilities

Volumn 4, Issue 3, 2010, Pages 4-11

  Unwin, Gemma ^a   Deb, Shoumitro ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

Intellectual disability; Learning disabilities; Medication; National guideline; Problem behaviour

Indexed keywords

EID: 84993054032     PISSN: 20441282     EISSN: 20441290     Source Type: Journal    
DOI: 10.5042/amhid.2010.0538     Document Type: Review

References (39)

1. Aman M.G., De Smedt G., Derivan A., Lyons B. & Findling R.L. (2002) The Risperidone Disruptive Behavior Study Group: risperidone treatment of children with disruptive behavior disorders and subaverage IQ: a double-blind, placebo-controlled study. American Journal of Psychiatry 159 1337-1346.
2. Bodfish J.W. & Madison J.T. (1993) Diagnosis and fluoxetine treatment of compulsive behavior disorder of adults with mental retardation. American Journal on Mental Retardation 98 (3) 360-367.
3. Branford D., Bhaumik S. & Naik B. (1998) Selective serotonin re-uptake inhibitors for the treatment of perseverative and maladaptive behaviours of people with intellectual disability. Journal of Intellectual Disability Research 42 (4) 301-306.
4. Buitelaar J.K., van der Gaag R.J., Cohen-Kettenis P. & Melman C.T. (2001) A randomized controlled trial of risperidone in the treatment of aggression in hospitalized adolescents with subaverage cognitive abilities. Journal of Clinical Psychiatry 62 239-248.
5. Casner J.A., Weinheimer B. & Gualtieri C.T. (1996) Naltrexone and self-injurious behaviour: a retrospective population study. Journal of Clinical Psychopharmacology 16 389-394.
6. Clarke D.J., Kelley S., Thinn K., & Corbett J.A. (1990) Psychotropic drugs and mental retardation: I. Disabilities and the prescription of drugs for behaviour and for epilepsy in three residential settings. Journal of Mental Deficiency Research 28 229-233.
7. Cook E.H. Jr, Rowlett R., Jaselskis C. & Leventhal B.L. (1992) Fluoxetine treatment of children and adults with autistic disorder and mental retardation. Journal of the American Academy of Child and Adolescent Psychiatry 31 (4) 739-745.
8. Davanzo P.A., Belin T.R., Widawski M.H. & King B.H. (1998) Paroxetine treatment of aggression and self-injury in persons with mental retardation. American Journal on Mental Retardation 102 (5) 427-437.
9. Deb S., Chaplin R., Sohanpal S., et al. (2008) The effectiveness of mood stabilisers and antiepileptic medication for the management of behaviour problems in adults with intellectual disabilities: a systematic review. Journal of Intellectual Disability Research 52 (2) 103-107.
10. Deb S., Clarke D. & Unwin G. (2006) Using Medication to Manage Behaviour Problems among Adults with a Learning Disability: Quick reference guide. Birmingham: University of Birmingham, Royal College of Psychiatrists and Mencap.
11. Deb S., Sohanpal S., Soni R., Lenotre L. & Unwin G. (2007) The effectiveness of antipsychotic medication in the management of behavioural problems in adults with intellectual disabilities. Journal of Intellectual Disability Research 51 (10) 766-777.
12. Deb S., Thomas M. & Bright C. (2001) Mental disorder in adults with intellectual disability. 2. The rate of behaviour disorders among a community-based population aged between 16 and 64 years. Journal of Intellectual Disability Research 45 506-514.
13. Findling R.L., Aman M.G., Eerdekens M., Derivan A. & Lyons B. (2004) The Risperidone Disruptive Behavior Study Group: long-term, open-label study of risperidone in children with severe disruptive behaviors and below-average IQ. American Journal of Psychiatry 161 677-684.
14. Janowsky D.S., Kraus J.E., Barnhill J., Elamir B. & Davis J.M. (2003) Effects of topiramate on aggressive, self-injurious, and disruptive/destructive behaviours in the intellectually disabled: an open-label retrospective study. Journal of Clinical Psychopharmacology 23 (5) 500-504.
15. Janowsky D.S., Shetty M., Barnhill J., Elamir B. & Davis J.M. (2005) Serotonergic antidepressant effects on aggressive, self-injurious and destructive/disruptive behaviours in intellectually disabled adults: a retrospective, open-label, naturalistic trial. International Journal of Neuropsychopharmacology 8 (1) 37-48.
16. King B.H. & Davanzo P. (1996) Buspirone treatment of aggression and self-injury in autistic and nonautistic persons with severe mental retardation. Developmental Brain Dysfunction 90 (1) 22-31.
17. La Malfa G., Bertelli M. & Conte M. (2001) Fluvoxamine and aggression in mental retardation. Psychiatric Services 52 (8) 1105.
18. La Malfa G.P., Bertelli M., Ricca V., Mannucci E. & Cabras P.L. (1997) Fluvoxamine and mental retardation: clinical use. Italian Journal of Intellective Impairment 10 (1) 3-6.
19. Langee H.R. (1990) Retrospective study of lithium use for institutionalized mentally retarded individuals with behavior disorders. American Journal on Mental Retardation 94 (4) 448-452.
20. Lewis M.H., Bodfish J.W., Powell S.B. & Golden R.N. (1995) Clomipramine treatment for stereotype and related repetitive movement disorders associated with mental retardation. American Journal of Mental Retardation 100 (3) 299-312.
21. Markowitz P.I. (1992) Effect of fluoxetine on self-injurious behavior in the developmentally disabled: a preliminary study. Journal of Clinical Psychopharmacology 12 (1) 27-31.
22. National Institute for Health and Clinical Excellence (NICE, 2004) Guideline Development Methods: Information for national collaborating centres and guideline developers. London: Author. Available www.nice.org.
23. Research Units on Pediatric Psychopharmacology (RUPP) Autism Network (2002) Risperidone in children with autism and serious behavioral problems. New England Journal of Medicine 347 314-321.
24. Research Units on Pediatric Psychopharmacology (RUPP) Autism Network (2005) Risperidone treatment of autistic disorder: longer-term benefits and blinded discontinuation after 6 months. American Journal of Psychiatry 162 1361-1369.
25. Ruedrich S., Swales T.P., Fossaceca C., Toliver J. & Rutkowski A. (1999) Effect of divalproex sodium on aggression and self-injurious behaviour in adults with intellectual disability: a retrospective review. Journal of Intellectual Disability Research 43 (2) 105-111.
26. Sandman C.A., Hetrick W.P., Taylor D.V., et al. (1993) Naltrexone reduces self-injury and improves learning. Experimental Clinical Psychopharmacololgy 1 242-258.
27. Sandman C.A., Hetrick W., Taylor D.V., et al. (2000) Long-term effects of naltrexone on self-injurious behavior. American Journal on Mental Retardation 105 103-107.
28. Shea S., Turgay A., Carroll A., et al. (2004) Risperidone in the treatment of disruptive behavioral symptoms in children with autistic and other pervasive developmental disorders. Pediatrics 114 e634-4l.
29. Smith S., Branford D., Collacott R., Cooper S.A. & McGrother C. (1996) Prevalence and cluster typology of maladaptive behaviours in a geographically defined population of adults with learning disabilities. British Journal of Psychiatry 169 219-227.
30. Snyder R., Turgay A., Aman M., et al. (2002) Effects of risperidone on conduct and disruptive behaviour disorders in children with subaverage IQs. Journal of the American Academy of Child and Adolescent Psychiatry 41 1026-1036.
31. Sohanpal S., Deb S., Thomas C., et al. (2007) The effectiveness of antidepressant medication in the management of behavioural problems in adults with intellectual disabilities: a systematic review. Journal of Intellectual Disability Research 51 (10) 750-755.
32. Troisi A., Vicario E., Nuccetelli F., Ciani N. & Pasini A. (1995) Effects of fluoxetine on aggressive behavior of adult inpatients with mental retardation and epilepsy. Pharmacopsychiatry 28 (3) 73-76.
33. Turgay A., Binder C., Snyder R. & Fisman S. (2002) Long-term safety and efficacy of risperidone for the treatment of disruptive behavior disorders in children with subaverage IQs. Pediatrics 110 e34.
34. Tyrer S.P., Aronson M.E. & Lauder J. (1993) Effect of lithium on behavioural factors in aggressive mentally handicapped subjects. In: NH Birch, C Padgham & MS Hughes (Eds) Lithium in Medicine and Biology. Carnforth: Marius Press.
35. Tyrer P., Oliver-Africano P.C., Ahmed Z., et al. (2008) Risperidone, haloperidol and placebo in the treatment of aggressive challenging behaviour in patients with intellectual disability: a randomised controlled trial. The Lancet 371 57-63.
36. Unwin G. & Deb S. (2006) Your Guide to Taking Medicine for Behaviour Problems: Easy read. Birmingham: University of Birmingham, Royal College of Psychiatrists and Mencap. www.LD-Medication.bham.ac.uk.
37. Van Bellinghen M. & De Troch C. (2001) Risperidone in the treatment of behavioural disturbances in children and adolescents with borderline intellectual functioning: a double-blind, placebo-controlled pilot trial. Journal of Child and Adolescent Psychopharmacology 1 1 5-13.
38. Verhoeven W.M.A. & Tuinier S. (2001) Cyclothymia or unstable mood disorder? A systematic treatment evaluation with valproic acid. Journal of Applied Research in Intellectual Disabilities 14 (2) 147-154.
39. Willemsen-Swinkels S.H.N., Buitelaar J.K., Nijhof G.J. & Van Engeland H. (1995) Failure of naltrexone hydrochloride to reduce self-injurious and autistic behavior in mentally retarded adults: double-blind placebo-controlled studies. Archives of General Psychiatry 52 766-773.